FindTrial
Sign In

Galectin-1 mediated NCAPG expression predicts prognosis in patients with gastric cancer

Galectin-1 mediated NCAPG expression predicts prognosis in patients with gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070242
Enrollment
Unknown
Registered
2023-04-06
Start date
2023-01-16
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Observation group:No

Sponsors

Jiangsu Taizhou People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Radical gastrectomy and D2 lymph node dissection, and postoperative pathology confirmed no tumor invasion at the incisal margin; 2. The postoperative pathological diagnosis was gastric adenocarcinoma; 3. Complete medical records after operation; 4. Complete clinical follow-up data.

Exclusion criteria

Exclusion criteria: 1. Palliative surgery; 2. Gastric stump cancer; 3. Received neoadjuvant chemotherapy; 4. With other malignant tumors or serious diseases.

Design outcomes

Primary

MeasureTime frame
Overall survival rate;disease free survival;—

Secondary

MeasureTime frame
Age;Sex;Tumor diameter;Pathological classification;Depth of invasion;Lymph node metastasis;TNM stage;—

Countries

China

Contacts

Public ContactXiaolan You

Jiangsu Taizhou People's Hospital

006586@yzu.edu.cn+86 139 5114 0047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026